Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MIST Milestone Pharmaceuticals Inc. Common Shares
$0.98 -6.67% -0.07
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MIST stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 122.0M
Enterprise value 109.3M
Trailing PE -1.3102666536967
Forward PE -1.2695595
PEG Ratio -0.26205333073934
Enterprise to EBITDA -1.398
Enterprise to revenue 46.662
Price to book MRQ 7.597675
Price to sales TTM 52.07873

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 2.3M
EBITDA -78207000
Diluted EPS TTM -0.65
Total Cash (MRQ) 170.6M
Current ratio (MRQ) 8.129
Operating Cash Flow (TTM) -61290000

MIST trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MIST News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.